These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35956093)

  • 1. Adenoid Cystic Carcinoma of the Breast May Be Exempt from Adjuvant Chemotherapy.
    Li L; Zhang D; Ma F
    J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35956093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Adjuvant Treatments for Adenoid Cystic Carcinoma of the Breast: A Population-Based, Propensity Score Matched Cohort Study from the SEER Database.
    Yang L; Wang C; Liu M; Wang S
    Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis comparison between intraoperative radiotherapy and whole-breast external beam radiotherapy for T1-2 stage breast cancer without lymph node metastasis treated with breast-conserving surgery: A case-control study after propensity score matching.
    Chen Q; Qu L; He Y; Xu J; Deng Y; Zhou Q; Yi W
    Front Med (Lausanne); 2022; 9():919406. PubMed ID: 35991652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of adjuvant chemotherapy in stage I-III male breast cancer: a SEER-based analysis.
    Li WP; Gao HF; Ji F; Zhu T; Cheng MY; Yang M; Yang CQ; Zhang LL; Li JQ; Zhang JS; Wang K
    Ther Adv Med Oncol; 2020; 12():1758835920958358. PubMed ID: 33014148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis stratification and postoperative radiation therapy utilization in adenoid cystic carcinoma of the breast.
    Zhang D; Li L; Ma F
    Breast; 2022 Dec; 66():40-48. PubMed ID: 36113374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis.
    Gao HF; Li WP; Zhu T; Yang CQ; Yang M; Zhang LL; Ji F; Cheng MY; Li JQ; Wang K
    Breast; 2020 Dec; 54():79-87. PubMed ID: 32947149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Demographic Factors, Treatment Patterns, and Overall Survival Associated With Rare Triple-Negative Breast Carcinomas in the US.
    Elimimian EB; Samuel TA; Liang H; Elson L; Bilani N; Nahleh ZA
    JAMA Netw Open; 2021 Apr; 4(4):e214123. PubMed ID: 33844001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of adjuvant radiotherapy after breast-conserving surgery in elder women with early-stage breast cancer: a propensity-score matching analysis.
    Han T; Shi M; Chen Q; Chen D; Hao J
    Front Oncol; 2023; 13():1012139. PubMed ID: 37901322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.
    Chen QX; Li JJ; Wang XX; Lin PY; Zhang J; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(4):6206-6215. PubMed ID: 28008158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy.
    Fu WF; Chen QX; Wang XX; Zhang J; Song CG
    Front Oncol; 2020; 10():1753. PubMed ID: 33102205
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database.
    Du ZL; Wang Y; Wang DY; Zhang L; Bian ZM; Deng Y; Xu CS; Lin DC; Xie L; Jia Y; Gao JD; Zhang BL
    Breast Cancer Res Treat; 2020 Sep; 183(2):429-438. PubMed ID: 32647940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
    Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
    JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of postoperative radiotherapy for non-metastatic head and neck adenoid cystic carcinoma based on SEER data.
    Du Y; Zeng Y
    J Int Med Res; 2022 Aug; 50(8):3000605221115151. PubMed ID: 35929027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impacts of Tumor Stage at Diagnosis and Adjuvant Therapy on Long-Term Survival Outcomes in Patients With Triple-Negative Breast Cancer Achieving Pathologic Complete Response After Neoadjuvant Chemotherapy.
    Chen AX; Chen X; Li XX; Guo ZY; Cao XC; Wang X; Zhang B
    Clin Breast Cancer; 2024 Jun; ():. PubMed ID: 38987035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0-1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database.
    Hu G; Hu G; Zhang C; Lin X; Shan M; Yu Y; Lu Y; Niu R; Ye H; Wang C; Xu C
    BMC Cancer; 2020 Feb; 20(1):136. PubMed ID: 32085753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of adjuvant chemotherapy on T1N0M0 breast cancer patients: a propensity score matching study based on SEER database and external cohort.
    Shen K; Yao L; Zhu J; Gu X; Wang J; Qian W; Zheng Z; Fu D; Wu S
    BMC Cancer; 2022 Aug; 22(1):863. PubMed ID: 35941565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population.
    Lim S; Park SH; Park HK; Hur MH; Oh SJ; Suh YJ
    PLoS One; 2015; 10(11):e0140208. PubMed ID: 26562837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
    He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
    Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Comparisons between Breast Conservation Surgery and Mastectomy Followed by Postoperative Radiotherapy in Stage I-III Breast Cancer Patients: Analysis of the Surveillance, Epidemiology, and End Results (Seer) Program Database.
    Xiang W; Wu C; Wu H; Fang S; Liu N; Yu H
    Curr Oncol; 2022 Aug; 29(8):5731-5747. PubMed ID: 36005190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant radiotherapy for patients with pathologic node-negative esophageal carcinoma: A population based propensity matching analysis.
    Gao HJ; Shang XB; Gong L; Zhang HD; Ren P; Shi GD; Wei YC; Yu ZT
    Thorac Cancer; 2020 Feb; 11(2):243-252. PubMed ID: 31828980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.